SCHEMBL24129456

SCHEMBL24129456

CCc1ccc(S(=N)(=O)CCO)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.50
▸ ALDH1A1 P00352 6/20 0.41
▸ HPGD P15428 1/20 0.41
▸ UCHL1 P09936 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA4 P22748 2/20 0.39
▸ CA6 P23280 2/20 0.39
▸ CA5A P35218 2/20 0.39
▸ CA7 P43166 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA14 Q9ULX7 2/20 0.39
▸ CA5B Q9Y2D0 2/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ TP53 P04637 1/20 0.38
▸ MAPT P10636 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24129793 0.82 CA2 (0.47) CA2ALDH1A1HPGDGAAL3MBTL1
SCHEMBL24129426 0.82 CA2 (0.59) CA2ALDH1A1HPGDUCHL1GAA
SCHEMBL24129791 0.81 CA2 (0.55) CA2ALDH1A1HPGDUCHL1GAA
SCHEMBL3650831 0.81 CA2 (0.60) CA2ALDH1A1HPGDUCHL1L3MBTL1
SCHEMBL24129423 0.78 KMT2A (0.46) CA2ALDH1A1HPGDUCHL1GAA
SCHEMBL24129790 0.77 KDM4E (0.45) CA2ALDH1A1HPGDGAAL3MBTL1
SCHEMBL17674086 0.77 PLCG1 (0.47) CA2KMT2ACA12CA1CA7
SCHEMBL31461328 0.76 SMN1; SMN2 (0.44) CA2ALDH1A1GAAL3MBTL1ATM
SCHEMBL23554860 0.74 CA2 (0.59) CA2ALDH1A1HPGDUCHL1GAA
SCHEMBL24129455 0.73 TP53 (0.50) CA2ALDH1A1UCHL1L3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257614-A1 HETEROCYCLIC INHIBITORS OF ENPP1 VOLASTRA THERAPEUTICS, INC. (US) 2021-12-23 — — WO disclosed
Send feedback